Trevi Therapeutics, Inc. (TRVI) News
Follow Trevi Therapeutics, Inc. (TRVI) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 12 public stories across 8 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
Harvest ETFs announces September 2026 Distributions
Harvest Portfolios Group Inc. (“Harvest”) announces the following monthly distributions for Harvest ETFs in the following table for the month ending September 30, 2026. The distributions will be paid on or about October
NEWS | Sep 23, 2026, 11:30 AM UTC
L
Trevi Therapeutics to participate in upcoming September conferences
Trevi Therapeutics says it will participate in upcoming September conferences, highlighting its investigational therapy Haduvio for chronic cough in patients with idiopathic pulmonary fibrosis and non-IPF.
EQUITY | Sep 03, 2026, 11:38 AM UTC
L
TRVI - Trevi Therapeutics to Participate in Upcoming September Conferences
TRVI - Trevi Therapeutics to Participate in Upcoming September Conferences
EQUITY | Sep 03, 2026, 11:30 AM UTC
L
Trevi Therapeutics to present at ERS Congress 2026
Trevi Therapeutics announced upcoming presentations at the European Respiratory Society (ERS) Congress 2026, per TradingView News.
GEOPOLITICS | Aug 26, 2026, 11:37 AM UTC
H
TRVI - Trevi Therapeutics Announces Upcoming Presentations at the European Respiratory Society (ERS) Congress 2026
TRVI - Trevi Therapeutics Announces Upcoming Presentations at the European Respiratory Society (ERS) Congress 2026
GEOPOLITICS | Aug 26, 2026, 11:30 AM UTC
L
TRVI - Trevi Therapeutics to Report Second Quarter 2026 Financial Results and Provide a Corporate Update on August 6, 2026 - Click For Relea
TRVI - Trevi Therapeutics to Report Second Quarter 2026 Financial Results and Provide a Corporate Update on August 6, 2026
EARNINGS | Jul 30, 2026, 08:05 PM UTC
L
TRVI - Trevi Therapeutics to Participate in Upcoming August Conferences
TRVI - Trevi Therapeutics to Participate in Upcoming August Conferences
EQUITY | Jul 28, 2026, 11:30 AM UTC
L
TRVI new Outperform W/ $36 PT @ BMO
TRVI new Outperform W/ $36 PT @ BMO
EQUITY | Jul 21, 2026, 11:15 AM UTC
L
TRVI lows -11%
TRVI lows -11%
EQUITY | Jul 20, 2026, 07:42 PM UTC
L
TRVI View GSK's decision to halt camlipixant in RCC as a positive for TRVI, ending the P2X3 class and leaving Haduvio the leading differenti
TRVI View GSK's decision to halt camlipixant in RCC as a positive for TRVI, ending the P2X3 class and leaving Haduvio the leading differentiated candidate; Briley reiterate Buy and raise PT to $31 from $21 @ Briley
EQUITY | Jul 20, 2026, 01:09 PM UTC
H
ManpowerGroup Posts Upbeat Q2 Earnings, Joins Docebo, Zentalis Pharmaceuticals And Other Big Stocks Moving Higher On Friday
U.S. stocks were lower, with the Nasdaq Composite falling around 400 points on Friday. Shares of ManpowerGroup Inc (NYSE: MAN ) rose sharply after the company reported upbeat second-quarter results and issued third-quart
EARNINGS | Jul 17, 2026, 02:09 PM UTC
L
TRVI highs up around 12%, benefiting from GSK stopping its Chronic cough study
TRVI highs up around 12%, benefiting from GSK stopping its Chronic cough study
EQUITY | Jul 17, 2026, 02:08 PM UTC